Stay updated with the latest receptor-biochemistry news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on receptor-biochemistry topics.
Researchers at the Tata Institute of Fundamental Research (TIFR), Hyderabad , have identified a mammalian protein, Cnpy1 (Canopy1), that is essential for the survival and function of vomeronasal sensory neurons in mice. Published in the journal Proceedings of the National Academy of Sciences (PNAS) , the study shows that Cnpy1 acts as a specialized endoplasmic‑reticulum‑associated factor required to maintain functional receptor complexes in these neurons, allowing them to thrive in an unusual ...Read More >
Bengaluru: Bangalore are you tired of trying viral trends and 'magic remedies' from social media to reduce weight? Today's youth want to be healthy, but a lack of correct information often leads them down the wrong path. Obesity is a complex medical condition that cannot be solved by a two-day diet or a viral challenge. What one needs is a scientific and reliable approach. The good news is that modern science now has a solution - called GLP1 RA (glucagon-like-peptide receptor agonist). This is a ...Read More >
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic's arrival is more than just a medical update, it could influence lifestyle choices for millions.Here's all we need to know about what this new ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals wit ...Read More >
New Delhi, Nov 26: The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study led by an Indian-origin researcher. Originally developed to treat diabetes, GLP-1 receptor agonists have significant benefits in people with and without diabetes, according to the study published in The Lancet Diabetes & Endocrinology. The drug stimulates insulin production and low ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.